(Q40647881)

English

ErbB1 and prostate cancer: ErbB1 activity is essential for androgen-induced proliferation and protection from the apoptotic effects of LY294002.

scientific article published on July 2003

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12746839%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

ErbB1 and prostate cancer: ErbB1 activity is essential for androgen-induced proliferation and protection from the apoptotic effects of LY294002 (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12746839%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

apoptotic process

0 references

Boe Sandahl Sorensen

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12746839%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

author name string

Niels Tørring

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12746839%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

Frederik Dagnaes-Hansen

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12746839%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

Ebba Nexø

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12746839%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

Nancy E Hynes

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12746839%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

publication date

1 July 2003

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12746839%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12746839%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

56

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12746839%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

142-149

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12746839%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12746839%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

Role of programmed (apoptotic) cell death during the progression and therapy for prostate cancer

1 reference

https://api.crossref.org/works/10.1002%2FPROS.10245

21 January 2018

The ErbB signaling network: receptor heterodimerization in development and cancer

1 reference

https://api.crossref.org/works/10.1002%2FPROS.10245

21 January 2018

Epidermal growth factor-related peptides and their receptors in human malignancies

1 reference

https://api.crossref.org/works/10.1002%2FPROS.10245

21 January 2018

Specificity within the EGF family/ErbB receptor family signaling network

1 reference

https://api.crossref.org/works/10.1002%2FPROS.10245

21 January 2018

ErbB-2, the preferred heterodimerization partner of all ErbB receptors, is a mediator of lateral signaling

1 reference

https://api.crossref.org/works/10.1002%2FPROS.10245

21 January 2018

Untangling the ErbB signalling network

1 reference

https://api.crossref.org/works/10.1002%2FPROS.10245

21 January 2018

Epidermal growth factor-related peptides and the epidermal growth factor receptor in normal and malignant prostate

1 reference

https://api.crossref.org/works/10.1002%2FPROS.10245

21 January 2018

Application of the MTT assay to human prostate cancer cell lines in vitro: establishment of test conditions and assessment of hormone-stimulated growth and drug-induced cytostatic and cytotoxic effects.

1 reference

https://api.crossref.org/works/10.1002%2FPROS.10245

21 January 2018

Possible autocrine loop of the epidermal growth factor system in patients with benign prostatic hyperplasia treated with finasteride: a placebo-controlled randomized study.

1 reference

https://api.crossref.org/works/10.1002%2FPROS.10245

21 January 2018

The EGF receptor family as targets for cancer therapy

1 reference

https://api.crossref.org/works/10.1002%2FPROS.10245

21 January 2018

Tyrosine kinase inhibitors: from rational design to clinical trials

1 reference

https://api.crossref.org/works/10.1002%2FPROS.10245

21 January 2018

Mammary glands reconstituted with Neu/ErbB2 transformed HC11 cells provide a novel orthotopic tumor model for testing anti-cancer agents

1 reference

https://api.crossref.org/works/10.1002%2FPROS.10245

21 January 2018

PTEN: life as a tumor suppressor

1 reference

https://api.crossref.org/works/10.1002%2FPROS.10245

21 January 2018

Androgens stimulate both growth rate and epidermal growth factor receptor activity of the human prostate tumor cell LNCaP.

1 reference

https://api.crossref.org/works/10.1002%2FPROS.10245

21 January 2018

ErbB2 is necessary for induction of carcinoma cell invasion by ErbB family receptor tyrosine kinases

1 reference

https://api.crossref.org/works/10.1002%2FPROS.10245

21 January 2018

The role of overexpressed HER2 in transformation

1 reference

https://api.crossref.org/works/10.1002%2FPROS.10245

21 January 2018

Her-2-neu expression and progression toward androgen independence in human prostate cancer.

1 reference

https://api.crossref.org/works/10.1002%2FPROS.10245

21 January 2018

A mechanism for hormone-independent prostate cancer through modulation of androgen receptor signaling by the HER-2/neu tyrosine kinase.

1 reference

https://api.crossref.org/works/10.1002%2FPROS.10245

21 January 2018

The molecular and cellular biology of HER2/neu gene amplification/overexpression and the clinical development of herceptin (trastuzumab) therapy for breast cancer.

1 reference

https://api.crossref.org/works/10.1002%2FPROS.10245

21 January 2018

An immunocytochemical analysis of TGF alpha expression in benign and malignant prostatic tumors

1 reference

https://api.crossref.org/works/10.1002%2FPROS.10245

21 January 2018

Adsorption of EGF receptor ligands to test tubes--a factor with implications for studies on the potency of these peptides

1 reference

https://api.crossref.org/works/10.1002%2FPROS.10245

21 January 2018

Androgenic regulation of growth factor and growth factor receptor expression in the CWR22 model of prostatic adenocarcinoma

1 reference

https://api.crossref.org/works/10.1002%2FPROS.10245

21 January 2018

c-erbB-2 oncoprotein: a potential biomarker of advanced prostate cancer

1 reference

https://api.crossref.org/works/10.1002%2FPROS.10245

21 January 2018

Identifiers

10.1002/PROS.10245

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12746839%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12746839%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40647881&oldid=1504034327"